Andrew Taylor to Echocardiography
This is a "connection" page, showing publications Andrew Taylor has written about Echocardiography.
Connection Strength
2.867
-
Gutman SJ, Shemesh E, Marwick TH, Taylor AJ. Echocardiographic screening to determine progression of latent rheumatic heart disease in endemic areas: A systematic review and meta-analysis. PLoS One. 2020; 15(6):e0234196.
Score: 0.615
-
Alexis JA, Costello B, Iles LM, Ellims AH, Hare JL, Taylor AJ. Assessment of the accuracy of common clinical thresholds for cardiac morphology and function by transthoracic echocardiography. J Echocardiogr. 2017 03; 15(1):27-36.
Score: 0.480
-
Papapostolou S, Kearns JS, Costello B, O'Brien J, Gutman S, Nanayakkara S, Kaye DM, Walton A, Hare J, Stub D, Taylor A. Relationship between left ventricular wall stress and cardiac remodelling post-TAVR and MitraClip. Open Heart. 2025 Aug 31; 12(2).
Score: 0.221
-
Papapostolou S, Kearns J, Costello BT, O'Brien J, Gutman SJ, Nanayakarra S, Kaye D, Walton A, Hare J, Stub D, Taylor AJ. Comparison of Pressure vs Volume Overload Ventricular Wall Stress in Patients With Valvular Heart Disease. J Am Coll Cardiol. 2024 Aug 13; 84(7):635-644.
Score: 0.205
-
Chong A, Stanton T, Taylor A, Prior D, La Gerche A, Anderson B, Scalia G, Cooke J, Dahiya A, To A, Davis M, Mottram P, Moir S, Playford D, Mahadavan D, Thomas L, Wahi S. 2024 CSANZ Position Statement on Indications, Assessment and Monitoring of Structural and Valvular Heart Disease With Transthoracic Echocardiography in Adults. Heart Lung Circ. 2024 Jun; 33(6):773-827.
Score: 0.202
-
Wahi S, Thomas L, Stanton T, Taylor A, Mahadevan D, Evans G, Playford D, To A, Davis M, Anderson B, Buckley B. CSANZ Imaging Council Position Statement on Echocardiography Services During the COVID-19 Pandemic. Heart Lung Circ. 2020 Jun; 29(6):e78-e83.
Score: 0.153
-
Krupickova S, Muthurangu V, Hughes M, Tann O, Carr M, Christov G, Awat R, Taylor A, Marek J. Echocardiographic arterial measurements in complex congenital diseases before bidirectional Glenn: comparison with cardiovascular magnetic resonance imaging. Eur Heart J Cardiovasc Imaging. 2017 Mar 01; 18(3):332-341.
Score: 0.123
-
Burrell AJ, Kaye DM, Fitzgerald MC, Cooper DJ, Hare JL, Costello BT, Taylor AJ. Cardiac magnetic resonance imaging in suspected blunt cardiac injury: A prospective, pilot, cohort study. Injury. 2017 May; 48(5):1013-1019.
Score: 0.123
-
Marwick TH, Taylor AJ. Contrast-Specific Imaging Without Contrast: An Echocardiographic Technique for the Detection of Myocardial Scar. JACC Cardiovasc Imaging. 2016 11; 9(11):1252-1254.
Score: 0.120
-
Daley J, Grotberg J, Pare J, Medoro A, Liu R, Hall MK, Taylor A, Moore CL. Emergency physician performed tricuspid annular plane systolic excursion in the evaluation of suspected pulmonary embolism. Am J Emerg Med. 2017 Jan; 35(1):106-111.
Score: 0.119
-
Ellims AH, Iles LM, Ling LH, Chong B, Macciocca I, Slavin GS, Hare JL, Kaye DM, Marasco SF, McLean CA, James PA, du Sart D, Taylor AJ. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype. Eur Heart J Cardiovasc Imaging. 2014 Oct; 15(10):1108-16.
Score: 0.101
-
Segan L, Prabhu S, Nanayakkara S, Taylor A, Hare J, Crowley R, William J, Cho K, Lim M, Koh Y, Das S, Chieng D, Sugumar H, Voskoboinik A, Ling LH, Costello B, Kaye DM, McLellan A, Lee G, Morton JB, Kalman JM, Kistler PM. Impact of Mitral Regurgitation on Outcomes of Catheter Ablation for AF With Left Ventricular Systolic Dysfunction. JACC Clin Electrophysiol. 2025 Aug; 11(8):1783-1794.
Score: 0.054
-
Smith J, Schrader S, Morgan H, Shenton P, Alafaci A, Cox N, Taylor AJ, Hare J, Jones B, Crawford NW, Buttery JP, Clothier HJ, Cheng DR. Clinical phenotype of COVID-19 vaccine-associated myocarditis in Victoria, 2021-22: a cross-sectional study. Med J Aust. 2025 01 13; 222(1):23-29.
Score: 0.053
-
Captur G, Manisty CH, Raman B, Marchi A, Wong TC, Ariga R, Bhuva A, Ormondroyd E, Lobascio I, Camaioni C, Loizos S, Bonsu-Ofori J, Turer A, Zaha VG, Augutsto JB, Davies RH, Taylor AJ, Nasis A, Al-Mallah MH, Valentin S, Perez de Arenaza D, Patel V, Westwood M, Petersen SE, Li C, Tang L, Nakamori S, Nezafat R, Kwong RY, Ho CY, Fraser AG, Watkins H, Elliott PM, Neubauer S, Lloyd G, Olivotto I, Nihoyannopoulos P, Moon JC. Maximal Wall Thickness Measurement in Hypertrophic Cardiomyopathy: Biomarker Variability and its Impact on Clinical Care. JACC Cardiovasc Imaging. 2021 11; 14(11):2123-2134.
Score: 0.041
-
McGiffin D, Kure C, McLean J, Marasco S, Bergin P, Hare JL, Leet A, Patel H, Zimmet A, Rix J, Taylor A, Kaye D. The results of a single-center experience with HeartMate 3 in a biventricular configuration. J Heart Lung Transplant. 2021 03; 40(3):193-200.
Score: 0.040
-
Sugumar H, Prabhu S, Voskoboinik A, Young S, Gutman SJ, Wong GR, Parameswaran R, Nalliah CJ, Lee G, McLellan AJ, Taylor AJ, Ling LH, Kalman JM, Kistler PM. Atrial Remodeling Following Catheter Ablation for Atrial Fibrillation-Mediated?Cardiomyopathy: Long-Term Follow-Up of CAMERA-MRI Study. JACC Clin Electrophysiol. 2019 06; 5(6):681-688.
Score: 0.036
-
Voskoboinik A, Wong MCG, Elliott JK, Costello BT, Prabhu S, Mariani JA, Kalman JM, Kistler PM, Taylor AJ, Morton JB. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2018 09; 41(9):1109-1115.
Score: 0.034
-
Fang L, Ellims AH, Moore XL, White DA, Taylor AJ, Chin-Dusting J, Dart AM. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. J Transl Med. 2015 Sep 24; 13:314.
Score: 0.028
-
Ellims AH, Taylor AJ, Mariani JA, Ling LH, Iles LM, Maeder MT, Kaye DM. Evaluating the utility of circulating biomarkers of collagen synthesis in hypertrophic cardiomyopathy. Circ Heart Fail. 2014 Mar 01; 7(2):271-8.
Score: 0.025
-
Chan W, Taylor AJ, Ellims AH, Lefkovits L, Wong C, Kingwell BA, Natoli A, Croft KD, Mori T, Kaye DM, Dart AM, Duffy SJ. Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2012 Apr; 5(2):270-8.
Score: 0.022
-
La Gerche A, Burns AT, Taylor AJ, Macisaac AI, Heidb?chel H, Prior DL. Maximal oxygen consumption is best predicted by measures of cardiac size rather than function in healthy adults. Eur J Appl Physiol. 2012 Jun; 112(6):2139-47.
Score: 0.021
-
Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, McNeil JJ. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry. 2011 Jun; 45(6):458-65.
Score: 0.020
-
Ronaldson KJ, Taylor AJ, Fitzgerald PB, Topliss DJ, Elsik M, McNeil JJ. Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls. J Clin Psychiatry. 2010 Aug; 71(8):976-81.
Score: 0.019
-
Khambadkone S, Coats L, Taylor A, Boudjemline Y, Derrick G, Tsang V, Cooper J, Muthurangu V, Hegde SR, Razavi RS, Pellerin D, Deanfield J, Bonhoeffer P. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation. 2005 Aug 23; 112(8):1189-97.
Score: 0.014